StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) stock

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$102.10−3.78 (-3.57%)

Close on Nov 18, 2026Market cap $4.56BP/E –Yield –

Grail revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Grail's revenue for the twelve months ending Jun 30, 2026 was $165.26M, up 23.1% year over year. For fiscal 2025 it was $147.17M, up 17.2% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$147.17M+17.2%
FY2024Dec 31, 2024$125.60M+34.9%
FY2023Dec 31, 2023$93.11M+67.6%
FY2022Jan 1, 2023$55.55M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.69M+25.7%
Q1 FY2026Mar 31, 2026$40.79M+28.1%
Q4 FY2025Dec 31, 2025$43.60M+14.0%
Q3 FY2025Sep 30, 2025$36.19M+26.3%
Q2 FY2025Jun 30, 2025$35.54M+11.2%
Q1 FY2025Mar 31, 2025$31.84M+19.1%
Q4 FY2024Dec 31, 2024$38.25M+26.1%
Q3 FY2024Sep 30, 2024$28.65M+38.3%
Q2 FY2024Jun 30, 2024$31.97M+42.6%
Q1 FY2024Mar 31, 2024$26.72M–
Q4 FY2023Dec 31, 2023$30.33M–
Q3 FY2023Oct 1, 2023$20.72M–
Q2 FY2023Jun 30, 2023$22.41M–

More Grail figures

See a number that looks wrong?